Navigation Links


antitumor at Biology News

Progress toward an antitumor vaccine

How can we induce the body to use its own weapon, the immune system, to battle cancer" In principle, by the same means used against infectious diseases: immunization. The production of a selective vaccine is not a trivial task, however. A team led by Horst Kunst at the University of Mainz has now found a way to bind a molecule that is typical for tumors to a carrier protein without irritating...
antitumor at Biology Products
antitumor at Biology Technology
antitumor at Medicine News

Benzotiophene derivatives exhibit antitumor activity

Raquel Villar Becares, Ph.D, student at Public University of Navarre has reported in her thesis that benzo[b]tiophene 1,1 dioxide is found to have anti-cancer effects//. She tested 24 compounds isolated from the derivatives and found 23 compounds from it had antitumor activity when tested in invitro cell cultures. Initial studies have found that the benzotiophene derivatives have antitumo...
antitumor at Medicine Products
antitumor at Medicine Technology

Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop

PRINCETON, N.J.--(BUSINESS WIRE)--Jun 28, 2007 - CytogenCorporation (NASDAQ: CYTO) reported updated data from a Phase 1dose escalation study evaluating QUADRAMET(R) (samarium Sm-153lexidronam injection) in combination with bortezomib (Velcade(R),Millennium Pharmaceuticals, Inc.) in patients with relapsedmultiple myeloma. Data from 33 patients were presented today in aposter titled, "Phase 1...

Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90 Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory Breast and Ovarian Cancers at ASCO

Clinical Benefit Shown in 35% of HER2-Positive Metastatic BreastCancer Patients HAYWARD, Calif., June 04, 2007 /PRNewswire-FirstCall/ -- KosanBiosciences Incorporated presented data from a Phase 1 clinicaltrial showing that alvespimycin, its second-generation Hsp90inhibitor, demonstrated promising antitumor activity andtolerability in combination with trastuzumab (Herceptin(R)) inpatient...

Kosan Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Epothilone KOS-1584 at ASCO

HAYWARD, Calif., June 04, 2007 /PRNewswire-FirstCall/ -- KosanBiosciences Incorporated presented data from a Phase 1 clinicaltrial showing that KOS-1584/R1645, an epothilone underco-development with Roche, demonstrated promising antitumoractivity and tolerability in patients with solid tumors.KOS-1584/R1645 showed activity in 32% of patients (13 of 41evaluable) including activity in pati...

Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing Promising Antitumor Activity in Multiple Myeloma at ASCO

Tanespimycin TIME Registration Program to Begin Third Quarter 2007 HAYWARD, Calif., June 04, 2007 /PRNewswire-FirstCall/ -- KosanBiosciences Incorporated presented data from a dose-escalatingPhase 1b clinical trial of its lead Hsp90 inhibitor, tanespimycin(KOS-953) in combination with bortezomib (Velcade(R)), showing ahigh degree of antitumor activity and tolerability in patients withmult...

Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO

HAYWARD, Calif., June 04, 2007 /PRNewswire-FirstCall/ -- KosanBiosciences Incorporated presented preliminary data from a Phase 2monotherapy trial showing that tanespimycin demonstrated antitumoractivity and tolerability in patients with metastatic melanoma,including one patient with a BRAF mutation (V600E) who had failedprior chemotherapy (within 6 weeks of initiation) and while ontanesp...

More>>

Other Tags
(Date:10/14/2008)... , The RightThing, leader...d outsourcing continues to show strong results in ...a, Praxair, Kronos, Roxanne, ABB, Siemens Candida ...ise recruitment process outsourcing (RPO) provider...ist. , (PRWEB) October 14...
(Date:10/14/2008)... , GIA Group, a global le...ic Analysis responds to customer needs by merging ... Germany and Netherlands, giving the group 10 offi...expertise in strategic analysis and industry verti...October 14, 2008 -- Global Intelligence Alliance (...
(Date:10/14/2008)... ASCOT, England, October 14 /PRNewswire/ -- R...ty of Strathclyde, have started work on a 3.5 year...gn incorporating CVD,(chemical vapour deposition) ...ix leads the world in the field of CVD diamond syn... diamond Raman laser could open up a raft of new,a...
(Date:10/13/2008)... ANN ARBOR, Mich., Oct. 13 /PRNewswire/ -- Th...pital in Albany, NY, has significantly improved,it...s discharge instruction,compliance for heart failu...7 to 100 percent in first-quarter 2008., St. Pete...ices of,Albany, is one of only 10 hospitals in the...
Breaking Medicine News(10 mins):Health News:The RightThing Continues Drive: Completes Strong Q3 2Health News:Global Intelligence Alliance Strengthens Group Organization and Adds Local Presence, Merges With Asian, German and Dutch Partner Companies 2Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 2Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 3Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 4Health News:St. Peter's Hospital of Albany Improves Core Measures Processes 2Health News:St. Peter's Hospital of Albany Improves Core Measures Processes 3
(Date:10/13/2008)...monstrates that the embryonic mouse heart has an a...viously observed only in non-mammalian species. Th... 14th issue of the journal Developmental Cell , d...the embryonic heart to replace diseased tissue thr..., Disorders of the mitochondria, a cell structur...
(Date:10/12/2008)... is also available in French . , Researchers ...axoSmithKline Inc. have identified two genetic var...nding sevenfold increase the risk of male pattern ...in the journal Nature Genetics. , About a thir... by age 45. The condition,s social and economic im...
(Date:10/10/2008)...ve identified stem cells with the capacity to buil...ssue of the journal Cell, a Cell Press publicati...can renew themselves, transplants of the progenito...e can restore normal fat tissue in animals that ar...nsight into the causes of obesity, a condition cha...
(Date:10/10/2008)...a MD, PhD, of Kyoto University and the Gladstone I...n another step forward in improving the possibilit...potent stem (iPS) cell technology. , Previously,...programmed to become embryonic stem celllike using...s required to reprogram the cells, and a virus to ...
Breaking Biology News(10 mins):Embryonic heart exhibits impressive regenerative capacity 2Researchers discover baldness gene: 1 in 7 men at risk 2Fat-regenerating 'stem cells' found in mice 2Yamanaka eliminates viral vector in stem cell reprogramming 2American Chemical Societys Weekly PressPac July 9 2008 4008 1American Chemical Societys Weekly PressPac July 9 2008 4008 2American Chemical Societys Weekly PressPac July 9 2008 4008 3American Chemical Societys Weekly PressPac July 9 2008 4008 4American Chemical Societys Weekly PressPac July 9 2008 4008 5American Chemical Societys Weekly PressPac July 9 2008 4008 6American Chemical Societys Weekly PressPac July 9 2008 4008 7American Chemical Societys Weekly PressPac July 9 2008 4008 8American Chemical Societys Weekly PressPac July 9 2008 4008 9New studies predict record land grab as demand soars for new sources of food energy and wood fiber 4003 1New studies predict record land grab as demand soars for new sources of food energy and wood fiber 4003 2New studies predict record land grab as demand soars for new sources of food energy and wood fiber 4003 3New studies predict record land grab as demand soars for new sources of food energy and wood fiber 4003 4New studies predict record land grab as demand soars for new sources of food energy and wood fiber 4003 5New studies predict record land grab as demand soars for new sources of food energy and wood fiber 4003 6FDA Accepts Gentas NDA Amendment as Complete Response for Genasense 28R 29 Treatment of Chronic Lymphocytic Leukemia 23893 1FDA Accepts Gentas NDA Amendment as Complete Response for Genasense 28R 29 Treatment of Chronic Lymphocytic Leukemia 23893 2FDA Accepts Gentas NDA Amendment as Complete Response for Genasense 28R 29 Treatment of Chronic Lymphocytic Leukemia 23893 3FDA Accepts Gentas NDA Amendment as Complete Response for Genasense 28R 29 Treatment of Chronic Lymphocytic Leukemia 23893 4MORSE LLC CyberKnife Centers of Miami and Palm Beach Mark Expansion Into Southwest Florida 23888 1
Other Contentswestwestwestmanagementmanagementmanagementmanagementmanagementmanagementmanagementmanagementmanagementweightweightweightweightweightweightweightweightweightweightwheezingwheezingwhiteheadwhiplashwhiplashcoughcoughcoughcoughwhoopingwhoopingwhooping